BWX Technologies, Inc. (BWXT) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 23, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for BWX Technologies, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, BWX Technologies, Inc.'s filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+12.13%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Turned Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does BWX Technologies, Inc. actually do?
Answer:
BWX Technologies, Inc. is a specialty manufacturer of nuclear components and a developer of nuclear technologies with over a century of operating history. The company's core focus is on the U.S. Government, particularly the design, engineering, and manufacture of naval nuclear components, reactors, and fuel for the U.S. Naval Nuclear Propulsion Program. BWXT also provides special nuclear materials processing, environmental site restoration, products and services for the nuclear power industry, and critical medical radioisotopes. Operating in two segments, Government Operations and Commercial Operations, the company relies heavily on large, long-term contracts, with the U.S. Government representing approximately 68% of its total consolidated revenues in 2025. BWXT is strategically expanding its capabilities through acquisitions, notably Aerojet Ordnance Tennessee, Inc. and Kinectrics, Inc., to enhance its offerings in advanced materials and lifecycle management services.
Question:
What are BWX Technologies, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by long-term contracts with the U.S. Government for naval nuclear components and fuel, as well as by demand in the commercial nuclear power industry for components, fuel, and services. The company also generates revenue from medical radioisotopes and radiopharmaceuticals.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required